Kliniska studier för Leukemi i Pennsylvania
15 studier för Leukemi söker deltagare vid platser i Pennsylvania.
Städer i Pennsylvania
Officiell studietext (engelska)
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital of Philadelphia, Philadelphia
RekryterarObservationsstudie
Ålder 0 till 38 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06131801A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- University of Pennsylvania, Philadelphia
RekryterarFas 1/2
30 Days · Alla kön · Uppdaterad 16 sep. 2026 · NCT04065399Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
- Spoknwrd Clinical Trials Inc., Easton
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT06824168Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Pittsburgh
RekryterarFas 3
Ålder 18 till 18 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07509151First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 1 sep. 2026 · NCT07586618Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Pennsylvania, Philadelphia
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT07007312Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 2
Ålder 7 till 25 · Alla kön · Uppdaterad 19 aug. 2026 · NCT05082519Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
RekryterarObservationsstudie
Ålder 60 och äldre · Alla kön · Uppdaterad 12 aug. 2026 · NCT03680677CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 1
Ålder 0 till 29 · Alla kön · Uppdaterad 7 juli 2026 · NCT07464951A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Dren Investigational Site 2, Pittsburgh
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 juni 2026 · NCT05475925Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Saint Christopher's Hospital for Children, Philadelphia
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 18 maj 2026 · NCT01790152Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 1/2
1 Month – 25 Years · Alla kön · Uppdaterad 15 apr. 2026 · NCT06839456A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Hospital of the University of Pennsylvania, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 13 mars 2026 · NCT05735184Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
- Children's Hospital of Philadelphia, Philadelphia
RekryterarTidig fas 1
Upp till ålder 30 · Alla kön · Uppdaterad 20 feb. 2026 · NCT02356653SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.